Clinical Presentations

  With this week’s Homerun Slides, we have a short special presentation for you on the new inhaled insulin, Afrezza, that goes with our exclusive interview by our publisher, Steve Freed, with the founder and CEO of Mannkind Corp, Al Mann….

As the diabetes epidemic continues to grow, practitioners are increasingly searching for medication solutions that can help patients to better manage their diabetes. This month, we have a recent slides series from the ADA showing the positive effects of adding-on SGLT-2 inhibitors to the medication regimen of patients on DPP-4’s …

  This week, we have a short set of Homerun Slides focusing on the effects of bromocriptine (Cycloset) on the biological clock….

  In this week’s Homerun Slides, Dr. Stanley Schwartz wraps up his presentation on the classification of diabetes based on the state of the beta-cells, and gives us some clear directions on how therapy could proceed in a patient-centric approach….

In this last of a comprehensive series of four Homerun Slides sets on SGLT-2 inhibitors, we delve deeper into how this drug class can work in challenging patient populations, incuding older and renally-impaired patients. In addition, the beneficial effects on weight and blood pressure are discussed…. To download the complete …

In this third set of a series of four Homerun Slides on SGLT-2 inhibitor medications, we cover LX4211, an SGLT-1 and SGLT-2 dual inhibitor, and then explore some of the safety concerns around SGLT-2 inhibitors including the safety of this drug class for older patients. We also review some of …

In this second set of a comprehensive four-part series of Homerun Slides on SGLT-2 inhibitors, we review some of the data of the second and third approved SGLT-2 inhibitors in the U.S., dapagliflozin (Farxiga) and empagliflozin (Jardiance), along with the Durability and Limitations of this drug class…. To download this …

In this first of a series of four sets of Homerun Slides, we review the basics of SGLT-2 inhibitors incuding Mode of Action, and Efficacy. and then look at how Canagliflozin has worked in poorly controlled type 2 diabetes patients…. To download the complete set in PowerPoint (.ppt) format, just …

  In this week’s Homerun Slides, Dr. Stanley Schwartz continues his exploration of a beta-cell centric classification model for diabetes and includes a detailed diagram explanation featuring the Egregious Eleven….

In this week’s Homerun Slides set, we look at Dr. Stanley Schwartz’s presentation from this year’s ADA with his groundbreaking proposal to classify diabetes using a ‘Beta-cell Centric’ approach….